SOP for Review and Approval of Registration Dossiers


Regulatory Affairs: SOP for Review and Approval of Registration Dossiers – V 1.0

Standard Operating Procedure for Review and Approval of Registration Dossiers

Department Regulatory Affairs
SOP No. RA/2026/658
Supersedes NA
Page No. 1 of X
Issue Date 10/04/2026
Effective Date 10/04/2026
Review Date 10/04/2028

Purpose

This Standard Operating Procedure (SOP) defines the systematic process for the comprehensive review and formal approval of registration dossiers intended for submission to regulatory authorities. It ensures that all dossiers meet applicable regulatory requirements, internal quality standards, and completeness criteria prior to submission, facilitating timely market authorization and compliance with global regulatory expectations.

Scope

This SOP applies to all registration dossiers prepared for any pharmaceutical dosage form, medical device, or related product within the organization intended for regulatory submission. It encompasses the review and approval activities carried out within the Regulatory Affairs department and interfaces with Quality Assurance, Clinical, Manufacturing, and other relevant departments. Activities excluded include post-approval regulatory maintenance and unrelated documentation processes.

Responsibilities

Functional roles involved include:

  • Regulatory Affairs Reviewers – responsible for detailed dossier examination against regulatory and organizational criteria.
  • Quality Assurance – responsible for verifying compliance with quality standards.
  • Subject Matter Experts (e.g., Clinical, Manufacturing) – provide technical evaluations relevant to their domain.
  • Regulatory Affairs Supervisors – oversee the review process, ensuring timelines and quality controls.
  • Approving Authorities – grant final approval for dossier submission.
See also  SOP for Regulatory Review of Product Labels and Cartons

Accountability

The Head of Regulatory Affairs is accountable for the implementation, continual compliance, and periodic review of this SOP, ensuring its effectiveness through periodic audits and managing escalation processes when deviations or bottlenecks arise.

Procedure

The review and approval of registration dossiers shall be executed in a structured and controlled manner to guarantee regulatory compliance and dossier integrity as follows:

1. Preparation and Prerequisites: Prior to initiating review, confirm receipt of a complete dossier package as per the predefined dossier checklist. Verify that all supporting documents, templates, and annexures are current and authorized. Ensure availability of applicable regulatory guidelines and internal SOPs.

2. Initial Completeness Check: Conduct a preliminary assessment to confirm the dossier contains all mandatory sections, forms, and data sets. Identify any missing elements or discrepancies and communicate with dossier preparers for rectification.

3. Detailed Technical Review: Regulatory Affairs Reviewers shall examine all components for accuracy, consistency, and regulatory alignment. Cross-check clinical data, manufacturing information, labeling, and quality control documentation. Subject Matter Experts shall verify technical sections related to their expertise.

4. Compliance and GMP Verification: Quality Assurance shall assess adherence to Good Manufacturing Practices (GMP), Good Clinical Practices (GCP), and other applicable standards within the dossier’s content.

5. Deviation Identification and Resolution: Document any nonconformities or potential risks identified during review. Raise corrective actions or clarifications through established channels. Follow up to ensure satisfactory resolution before proceeding.

6. Approval Workflow: Upon satisfactory review and resolution of issues, compile reviewer comments and recommendations. Submit the dossier and associated findings to the designated Approving Authorities within Regulatory Affairs. Approval shall only be granted after thorough evaluation and endorsement of dossier integrity and compliance.

7. Documentation and Record Keeping: Retain all review records, checklists, approval forms, and correspondence in accordance with internal document control and record retention policies. Ensure traceability of all changes, sign-offs, and review dates for audit readiness.

See also  SOP for Lifecycle Maintenance of Product Registrations

8. Closure and Submission Preparation: Post-approval, inform relevant departments to proceed with dossier submission as per regulatory timelines and procedures. Archive approved dossiers securely to maintain confidentiality and data integrity.

Throughout all stages, maintain effective communication between involved departments and ensure adherence to timelines to support timely regulatory submissions. This procedure must be periodically reviewed and updated to incorporate evolving regulatory requirements and organizational changes.

Abbreviations

  • GMP – Good Manufacturing Practices
  • GCP – Good Clinical Practices
  • QA – Quality Assurance
  • RA – Regulatory Affairs
  • SOP – Standard Operating Procedure

Documents

The following documents are essential for the review and approval process described in this SOP:

  1. Registration Dossier Checklist (Annexure-1)
  2. Dossier Review Comment Form (Annexure-2)
  3. Approval Form for Registration Dossier Submission (Annexure-3)

References

  • ICH Q10 – Pharmaceutical Quality System
  • FDA Guidance for Industry: Content and Format of Investigational New Drug Applications
  • EU Directive 2001/83/EC on the Community Code Relating to Medicinal Products
  • Internal Document Control SOP
  • Good Manufacturing Practices (GMP) as applicable

Version

1.0

Approval

Prepared By
Checked By
Approved By

Annexures

Annexure-1: Registration Dossier Checklist

Purpose: To verify completeness and presence of all required components within the registration dossier prior to detailed review.

Section Status (Yes/No) Comments
Cover Letter Yes Attached with correct date
Product Information Yes Includes dosage form and formulation
Clinical Data Yes All required study reports included
Manufacturing Process Description Yes Validated process details present
Quality Control Data Yes Analytical methods and results included
Labeling and Packaging Yes Approved artwork attached
Regulatory Forms and Declarations Yes Signed and dated as required
Other Supporting Documents Yes Environmental and safety data included

Annexure-2: Dossier Review Comment Form

Purpose: To document detailed observations, comments, and action items identified during the dossier review process.

Date Reviewer Role Section Reviewed Comments Action Required Status
05/04/2026 Regulatory Affairs Reviewer Clinical Data Missing stability report for study XYZ. Request stability report from Clinical Team. Open
06/04/2026 Quality Assurance Manufacturing Process Validation batch records incomplete. Follow-up with Manufacturing for completion. Open
08/04/2026 Regulatory Affairs Supervisor Overall Dossier All comments addressed satisfactorily. Proceed to Approval. Closed
See also  SOP for Regulatory Department Onboarding and Process Training

Annexure-3: Approval Form for Registration Dossier Submission

Purpose: To document formal authorization for the submission of the registration dossier to the relevant regulatory authority.

Document Title Registration Dossier for Product ABC
Date of Approval 09/04/2026
Approving Authority Head of Regulatory Affairs
Comments All reviews completed. Dossier approved for submission.
Signature _________________________

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
10/04/2026 1.0 Initial issue New SOP creation

Related Guidelines: